UNSPSC 51381511: Glafenine

This classification denotes an analgesic agent with the molecular formula C19H17ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46HL4I09AH, chemically known as 2,3-dihydroxypropyl n-(7-chloro-4-quinolyl) anthranilate but generally known as glafenine, which bears US NIH Compound Identifier 3474. European Medicines Agency schedules Glafenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07909MIG. The term GLAFENINE is an International Non-Proprietary Name.

UNSPSC 51381511 Glafenine is a Commodity code that does not align with the recent state and local procurement activity posted under it. The three most recent opportunities—a naloxone and drug deactivation systems procurement from Seminole County, Florida; a Therapeutic Pharmacy Initiative direct-to-manufacturer RFI from the Texas Health and Human Services Commission; and a generic multi-source pharmaceuticals and OTC products cooperative purchasing RFP from the Minnesota Multistate Cooperative Purchasing Alliance—do not involve glafenine or medications in the glafenine category. The code appears to capture niche pharmaceutical procurement activity, but the opportunities currently tagged to it reflect broader state and local health agency purchasing of emergency response supplies, prescription fulfillment infrastructure, and generic drug distribution agreements rather than glafenine-specific sourcing.

The issuing bodies span state health departments (Texas HHS), county health agencies (Seminole County), and multi-state cooperative purchasing vehicles (MMCAP, which serves Minnesota and Oregon), indicating that when activity does occur under this code, it typically involves health and human services procurement offices managing drug inventory and supply chain agreements. Geographic activity is distributed across Florida, Texas, Minnesota, and Oregon, with no clear concentration. Because the recent opportunities are misaligned with the code's nominal scope, this code shows little relevant market activity for glafenine itself and warrants verification before pursuing opportunities tagged to it.